Chemical modifications can improve stability, alter pharmacokinetics, or enhance target selectivity, potentially addressing traditional limitations of peptide drugs
Outside the brain, dopamine is synthesized in several tissues including the gastrointestinal system where its actions reduce gastrointestinal motility, the pancreas where its actions inhibit insulin synthesis, and in the kidneys where its actions increase sodium excretion and urinary output
(2013) reported no significant variations in key pharmacokinetic parameterspeak time (Tmax), t1/2, and AUCbetween Day 1 and Day 7, suggesting stable pharmacokinetics with prolonged administration
Delivery, and especially Controlled Release of Antioxidants : Traditional drug delivery systems do not provide a prolonged beneficial antioxidant effect of the drugs, which in nanoparticle-based systems can be precisely controlled for release [17]
hormonal changes, fertility, onset of puberty and regulation of bone mass [167]